Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

Friday, January 8, 2010 Press Release J E 4

ALISO VIEJO, Calif., Jan. 6 Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive officer, will make a presentation at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010 at 8:30 a.m. PST. The conference will be held at The Westin St. Francis Hotel in San Francisco.

A live webcast and audio archive will be available on the company's Web site at Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL:

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at


Contact: Laurie Little Valeant Pharmaceuticals 949-461-6002

SOURCE Valeant Pharmaceuticals International


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Bristol-Myers Squibb/AstraZeneca's Onglyza Will Ga...
Watson to Present at 28th Annual JPMorgan Healthca...